FICOSOTA – Trademark Portfolio

Entity Type: 16

FICOSOTA holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ORFE. The owner is based in Sofia.

102 Bulgaria Blvd. Bellissimo Busns Ctr

Sofia 1680 , BG

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ORFE
ORFE
Registered 2018
ORFE
ORFE
Registered 2018
ORFE
ORFE
Abandoned 2018
O F R E
O F R E
Abandoned 2018
BEBBÉ
BEBBÉ
Abandoned 2017
BABIFY
BABIFY
Abandoned 2017

Trademark Classifications

FICOSOTA's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (7 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does FICOSOTA have?

FICOSOTA has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 abandoned.

What trademark classes does FICOSOTA file in?

FICOSOTA files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are FICOSOTA's most well-known trademarks?

FICOSOTA's registered trademark portfolio includes well-known marks such as ORFE. These are among 2 currently registered trademarks in the portfolio.

What is FICOSOTA's trademark registration success rate?

FICOSOTA has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.